Industry leaders say annual screenings for service members could improve troop readiness, expand diagnosis of hypogonadism and treatment.
Browsing: health policy
Dr. Vinay Prasad’s resignation from the FDA amid political pressure and controversy highlights ongoing debates over drug approval standards and regulatory transparency in healthcare.
The U.S.–EU trade agreement sparks uncertainty in the pharmaceutical sector, risking $100 billion in EU investments and disrupting global drug supply chains and innovation.